Across thousands of members, weve seen: 16.7% average weight loss in 12 months Achieved using 66% less GLP-1 medication than traditional programs 8 in 10 members taper off without regaining weight What a high-ROI GLP-1 benefit looks like If you want to make covering GLP-1s sustainable, your benefit should include: 1
Glucagon-like peptide-1 receptor agonists do not increase aspiration during upper endoscopy in patients with diabetes
This means they minimize hunger and cravings, leaving people feeling satisfied with smaller portions
FDA notice on Zepbound/ Mounjaro shortage: On October 2, 2024, the U.S
Mol Cell Endocrinol 2015;402:43-50.ArticlePubMed 99
These appetite-suppressing treatments can help you manage hunger, support metabolic health, and make lasting progress